Solid Biosciences Inc. (NASDAQ:SLDB) Receives $14.90 Consensus PT from Analysts
Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have been given a consensus rating of “Buy” by the thirteen brokerages that are covering the stock, Marketbeat reports. Ten equities research analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average twelve-month […]
Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have been given a consensus rating of “Buy” by the thirteen brokerages that are covering the stock, Marketbeat reports. Ten equities research analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average twelve-month […]
